BMJ  2006;333:507-508 (9 September), doi:10.1136/bmj.38960.600822.80

Editorial

Non-steroidal anti-inflammatory drugs after hip replacement

Inhibit ectopic bone growth but do not reduce pain or disability

The first 150 words of the full text of this article appear below.

The risks of cardiovascular and cerebrovascular toxicity associated with non-steroidal antiinflammatory drugs (NSAIDs)^{1 2} have prompted reappraisal of the use of these drugs and led to the inclusion of "black box" warnings in related prescribing information in the United States.³ The European Medicines Agency may also extend its warnings, given that the Medicines and Healthcare Products Regulatory Agency is considering unpublished data from a new clinical trial⁴ along with all other evidence and is seeking expert advice this month from the Commission on Human Medicines (MHRA, personal communication, 2006).

Clinicians now avoid the use of NSAIDs in patients with established atheromatous disease. In this week's BMJ, however, Fransen and colleagues remind us that this class of drugs has many potential uses including inhibition of ectopic bone formation after joint replacement and postoperative pain relief.⁵ The authors report a randomised placebo controlled trial of a modest two week dose of . . . [Full text of this article]

Northumbria Healthcare NHS Trust and School of Clinical Medical Sciences, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH
(Fraser.Birrell@ncl.ac.uk)

Department of Orthopaedics, University Hospital in Lund, SE-22185 Lund, Sweden

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial

Marlene Fransen, Craig Anderson, Jan Douglas, Stephen MacMahon, Bruce Neal, Robyn Norton, Mark Woodward, Ian D Cameron, Ross Crawford, Sing Kai Lo, Garnet Tregonning, Margaret Windolf HIPAID Collaborative Group
BMJ 2006 333: 519. [Abstract] [Full Text] [PDF]

Understanding the NSAID related risk of vascular events

Harald E Vonkeman, Jacobus R B J Brouwers, and Mart A F J van de Laar
BMJ 2006 332: 895-898. [Extract] [Full Text] [PDF]

The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review

Lee Hooper, Tamara J Brown, Rachel Elliott, Katherine Payne, Chris Roberts, and Deborah Symmons
BMJ 2004 329: 948. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Halvorsen, K, Slettebo, A, Nortvedt, P, Pedersen, R, Kirkevold, M, Nordhaug, M, Brinchmann, B S (2008). Priority dilemmas in dialysis: the impact of old age. J. Med. Ethics 34: 585-589 [Abstract] [Full text]  
• Pedersen, R, Nortvedt, P, Nordhaug, M, Slettebo, A, Grothe, K H, Kirkevold, M, Brinchmann, B S, Andersen, B (2008). In quest of justice? Clinical prioritisation in healthcare for the aged. J. Med. Ethics 34: 230-235 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

drugs after hip replacement

Howard J Homler
bmj.com, 9 Sep 2006 [Full text]

NSAIDs and orthopaedic surgery

James S Dawson
bmj.com, 10 Sep 2006 [Full text]

Online poll

Find out more here>> and here>>